Pancheri, E.; Guglielmi, V.; Wilczynski, G.M.; Malatesta, M.; Tonin, P.; Tomelleri, G.; Nowis, D.; Vattemi, G.
Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects. Cancers 2020, 12, 2540.
https://doi.org/10.3390/cancers12092540
AMA Style
Pancheri E, Guglielmi V, Wilczynski GM, Malatesta M, Tonin P, Tomelleri G, Nowis D, Vattemi G.
Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects. Cancers. 2020; 12(9):2540.
https://doi.org/10.3390/cancers12092540
Chicago/Turabian Style
Pancheri, Elia, Valeria Guglielmi, Grzegorz M. Wilczynski, Manuela Malatesta, Paola Tonin, Giuliano Tomelleri, Dominika Nowis, and Gaetano Vattemi.
2020. "Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects" Cancers 12, no. 9: 2540.
https://doi.org/10.3390/cancers12092540
APA Style
Pancheri, E., Guglielmi, V., Wilczynski, G. M., Malatesta, M., Tonin, P., Tomelleri, G., Nowis, D., & Vattemi, G.
(2020). Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects. Cancers, 12(9), 2540.
https://doi.org/10.3390/cancers12092540